Christopher Schaich to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Christopher Schaich has written about Randomized Controlled Trials as Topic.
Connection Strength
0.049
-
Teixeira JP, Perez Ingles D, Barton JB, Dean JT, Garcia P, Kunkel SJ, Sarangarm P, Weiss NK, Schaich CL, Busse LW, Nielsen ND. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock. Trials. 2024 Mar 12; 25(1):182.
Score: 0.049